Robert D. Mitchell



For more than 25-years, Mr. Mitchell served in multiple senior leadership capacities leading high technology medical device companies. In 2008, he was the President and Chief Executive Officer for Nellix Inc. in Palo Alto California, a privately held medical device company specializing in the endovascular treatment of Abdominal Aortic Aneurysms. In January 2011, Nellix was sold to NASDAQ listed Endologix Inc. where he was President for several years. In January 2018, Mr. Mitchell assumed President Emeritus status for Endologix to dedicate more time to a few specific boards and

investments he has made over the years.


In 2005, Mr. Mitchell served as Chief Operating Officer & Executive Vice President of New York

based AngioDynamics, a NASDAQ-listed public company and leading provider of innovative

medical devices to treat cancer and peripheral vascular disease. During his tenure, he oversaw

the acquisition of RITA Medical. Prior to this, Mr. Mitchell served as Chairman, President and

Chief Executive Officer of Millimed Holdings, Inc., a privately held company in Roskilde,

Denmark, developing next-generation drug eluting products for vascular disease. Much of Mr.

Mitchell's professional experience (1986 – 2002) was at Cook Medical Inc., the world’s largest

privately held medical device company, where he was accountable for revenues in excess of a

billion dollars. As Senior Vice President, living in Bloomington Indiana, he led Cook’s largest

revenue generating business units including: interventional radiology, cardiology, endovascular,

critical care and surgical. Following his time at Cook, he served as Vice President of Worldwide

Sales for NASDAQ-listed Align Technology (Invisalign), Inc. of Santa Clara, California.


Mr. Mitchell is a Senior Advisor for TVM Capital in Dubai and was a General Partner and cofounder

of Summit Life Science Partners, an early stage medical device venture fund based in

Park City, UT. He has been an advisor to more than 20 humanitarian and/or healthcare

companies serving as a member of the board for several including the American Heart

Association (Bloomington, Indiana and Irvine, California), NeoSci International Inc. (Singapore),

HeartFlow Inc. (Stanford University, Palo Alto, California) and JenaValve, (Irvine California). He

is currently chairman of the board for Amecath Inc. (Cairo, Egypt) and PULSE Therapeutics (St.

Louis, Mo). Throughout his career, Mr. Mitchell has authored and/or coauthored multiple

medical publications, technical papers and clinical presentations. In addition, he has been

frequent invited lecturer and keynote speaker in more than 15 countries.


Mr. Mitchell received his Bachelor of Science degree in Economics from the University of Utah

and his MBA from Wesleyan University (Indiana).



About Our



© 2019 Vivos Therapeutics, Inc.  ALL RIGHTS RESERVED

All content found on the vivoslife.com website, including text, images, audio, or other formats were created for informational purposes only. The content of this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Individual results may vary. Nothing contained in this website infers or creates a warranty, promise, or guarantee of any kind with respect to the clinical outcome or result from treatment using the Vivos technology. The use of the Vivos technologies by any patient must always occur under the direction and supervision of a qualified, trained, and licensed dentist, physician or other qualified health provider, working in close collaboration with qualified medical personnel.